Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea

INTRODUCTION: Golimumab is a human monoclonal antibody that inhibits tumor necrosis factor-α (TNF-α). Inhibition of TNF-α by golimumab inhibits the inflammatory response, thereby modulating the immune response in immune-mediated inflammatory diseases. Although the efficacy of golimumab has been demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeongyeong, Kim, Youngdoe, Lee, YoungJa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380597/
https://www.ncbi.nlm.nih.gov/pubmed/34324171
http://dx.doi.org/10.1007/s40744-021-00352-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380597/
https://www.ncbi.nlm.nih.gov/pubmed/34324171
http://dx.doi.org/10.1007/s40744-021-00352-6

Ejemplares similares